9,51 $
2,15 % gestern
Nasdaq, 1. Mai, 22:10 Uhr
ISIN
US2928121043
Symbol
ENFN
Berichte

Enfusion Aktie News

Neutral
Business Wire
14 Tage alt
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its first quarter 2024 financial results before the U.S. financial markets open on Thursday, May 9, 2024. Management will host a conference call and webcast that same morning at 5:30 AM (PT...
Neutral
PRNewsWire
20 Tage alt
NEW YORK , April 12, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
PRNewsWire
27 Tage alt
NEW YORK , April 4, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Positiv
InvestorPlace
28 Tage alt
Discovering and allocating to undervalued stocks is a key element of successful investing. Stocks are considered “undervalued” when they trade below what people think their intrinsic value is.
Neutral
Business Wire
30 Tage alt
ATLANTA--(BUSINESS WIRE)-- #simplyconnectingpayments--ConnexPay has announced the appointment of Ben Peters as chief executive officer. Peters brings more than two decades of experience.
Positiv
Seeking Alpha
etwa ein Monat alt
ENFN reported solid Q4 earnings with accelerating revenue growth and a strong pipeline. The company is successfully penetrating the total addressable market (TAM) in the asset management industry. ENFN's focus on product innovation and total cost of ownership (TCO) advantage will drive future growth and close the valuation gap with peers.
Neutral
PRNewsWire
etwa ein Monat alt
NEW YORK , March 27, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
Business Wire
etwa ein Monat alt
NEW YORK--(BUSINESS WIRE)--Enfusion, a best-in-class software-as-a-service (SaaS) platform for investment managers, today announced the completion of the second phase of a strategic investment management platform migration by Kayne Anderson. Kayne Anderson is a leading alternative investment management firm focused on real estate, infrastructure, energy, credit, and growth capital. The first ph...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen